← Back
$ACRV All transactions

Acrivon Therapeutics, Inc.

A

$ Value

$0

Shares

20,275

Price

$0

Filed

Jun 17

Insider

Name

DiRocco Derek

Title

CIK

0001792061

Roles

Director

Transaction Details

Transaction Date

2025-06-13

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

20,275

Footnotes

The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through the applicable vesting date. | Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the stock option for the benefit of RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund and the Nexus Fund II. The Reporting Person therefore disclaims beneficial ownership of the stock option and underlying Common Stock.

Filing Info

Accession No.

0000905148-25-002177

Form Type

4

Issuer CIK

0001781174

DiRocco Derek's History

Date Ticker Type Value
2025-06-13 ACRV A $0

Other Insiders at ACRV (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. 2026-04-22
Miller Mary
Chief Legal Officer
2026-04-17